Context Therapeutics Inc. (Nasdaq: CNTX), a clinical-stage biopharmaceutical company, was added to the Russell 2000 and Russell 3000 indexes ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE